PharmaCyte Biotech, Inc. Total Revenue

• This data is from PharmaCyte Biotech, Inc.'s annual report (Form 10-K), filed with the SEC on August 11, 2025.
• XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q3 2013: $0.00 | Q4 2013: $0.00 | Q1 2014: $0.00 | Q2 2014: $0.00 | Q3 2014: $0.00 | Q4 2014: $0.00 | Q1 2015: $0.00 | Q2 2015: $0.00 | Q3 2015: $0.00 | Q4 2015: $0.00 | Q1 2016: $0.00 | Q2 2016: $0.00 | Q3 2016: $0.00 | Q4 2016: $0.00 | Q1 2017: $0.00 | Q2 2017: $0.00 | Q3 2017: $0.00 | Q4 2017: $0.00 | Q1 2018: $0.00 | Q3 2018: $0.00 | Q4 2018: $0.00 | Q1 2019: $0.00 | Q3 2019: $0.00 | Q4 2019: $0.00 | Q1 2020: $0.00 | Q3 2020: $0.00 | Q4 2020: $0.00 | Q1 2021: $0.00 | Q3 2021: $0.00 | Q4 2021: $0.00 | Q1 2022: $0.00 | Q3 2022: $0.00 | Q4 2022: $0.00 | Q1 2023: $0.00 | Q3 2023: $0.00 | Q4 2023: $0.00 | Q1 2024: $0.00 | Q3 2024: $0.00 | Q4 2024: $0.00 | Q1 2025: $0.00 | Q3 2025: $0.00 | Q4 2025: $0.00 | Q1 2026: $0.00.
• Over the full 15 years of available data (2011 to 2025), PharmaCyte Biotech, Inc.'s Total Revenue has declined by 100.0%.
• Historical annual values: Fiscal year 2025: $0.00 | Fiscal year 2024: $0.00 | Fiscal year 2023: $0.00 | Fiscal year 2022: $0.00 | Fiscal year 2021: $0.00 | Fiscal year 2020: $0.00 | Fiscal year 2019: $0.00 | Fiscal year 2018: $0.00 | Fiscal year 2017: $0.00 | Fiscal year 2016: $0.00 | Fiscal year 2015: $0.00 | Fiscal year 2014: $0.00 | Fiscal year 2013: $12.2 thousand | Fiscal year 2012: $66.6 thousand | Fiscal year 2011: $126.0 thousand.
• Data sourced from SEC EDGAR public filings as of August 5, 2026.

Last verified: August 5, 2026